RM
RP Management Portfolio holdings
AUM
$139M
This Quarter Return
-15.65%
1 Year Return
-37.98%
3 Year Return
+207.23%
5 Year Return
+1,005.94%
10 Year Return
–
AUM
$146M
AUM Growth
–
Cap. Flow
+$146M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
4
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$78.1M |
| 2 |
IMMU
Immunomedics Inc
IMMU
|
$62.4M |
| 3 |
Cytokinetics
CYTK
|
$5.53M |
| 4 |
VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
|
$54K |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 57.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BHVN
1
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $78.1M | 53.45% |
+2,111,111
| New | +$78.1M |
|
|
IMMU
2
DELISTED
Immunomedics Inc
IMMU
| $62.4M | 42.73% |
+4,373,178
| New | +$62.4M |
|
|
3
Cytokinetics
CYTK
$4.23B
| $5.53M | 3.79% |
+875,656
| New | +$5.53M |
|
|
VIRX
4
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $54K | 0.04% |
+129,517
| New | +$54K |
|